European Journal of Immunology · 2002 · 65 citations · 35 references
Life SciencesCell BiologyImmunologyInflammationInnate ImmunityVaccine ImmunologyCell-mediated ImmunityCytokine BiologyDendritic Cell BiologyImmune MaturationInnate Immune ActivationNeonatal ImmunityAdjuvant MechanismsCytokine SynthesisImmune Cell Cytokine ProductionInflammatory Cytokine ProductionMhc Class Ii MoleculesNeonatal Dendritic CellsNuclear Factor Kappa B ActivationVaccine Adjuvant Development
Bordetella pertussis toxin (PTX), a key component of acellular pertussis vaccines, is known to be endowed with adjuvant properties. In experiments designed to get insights into the interactions between PTX and circulating immune cells, we first observed that addition of PTX to adult whole blood induced the release of IL-12 and TNF-alpha as well as maturation of myeloid dendritic cells (DC). These effects were still present with a toxin mutant devoid of ADP-ribosyltransferase activity but not with a formaldehyde-inactivated toxin. These findings indicate that cytokine production and DC maturation require the intact structure of PTX but not its enzymatic activity. Secondly, studies on DC generated in vitro by culturing monocytes with IL-4 and GM-CSF showed that PTX directly stimulates MHC class II and costimulatory molecules up-regulation, cytokine synthesis and NF-kappa B activation. Finally, comparison of data obtained in adult vs. cord blood revealed deficient responses of neonatal DC to PTX. These data suggest new applications of PTX and PTX mutants as vaccine adjuvants.
35
Proliferating dendritic cell progenitors in human blood.
Nikolaus Romani, Susanne Grüner, D Brang et al. · The Journal of Experimental Medicine · 1994 · 1.9K citations · Full text
Susan L. Prescott, Claudia Macaubas, Barbara J. Holt et al. · The Journal of Immunology · 1998 · 789 citations · Full text
Life Sciences, Immunology, Allergy +16